In the latest episode of the Drug Science Podcast, David Nutt sits down with Zoe Cormier, author of ‘Sex, Drugs and Rock and Roll’. In this episode, Zoe draws upon her two great passions of music and science and how these lead to her interest around Drugs - she discusses the current landscape of drug policy, drawing upon similarities and differences between the UK, Canada, and the US. She shares insight on the political situation in the US, with reference to recent elections and the potential impact this may have on future drug policy.

Sex, Drugs and Rock and Roll Book

Cannabis

LSD

Psilocybin

MDMA

DMT

MDMA for PTSD

MAPS Canada

MAPS Incident

Schizophrenia

Skunk

Inuits

Donald Trump

Joe Biden

Monty Python

Roald Dahl

Manifest destiny

Glastonbury festival

Small Pharma

Fibromyalgia

Breaking Convention

Support the podcast

In this episode of the Drug Science Podcast, we hear from Andrew Feldmár, a psychotherapist with over 52 years of experience. He discusses his journey into psychotherapy, his departure from mainstream psychiatric and therapeutic practices rooted in the concept of mental illness, and his experiences with LSD. Feldmár also critiques various techniques used in contemporary psychedelic research and offers a fresh perspective based on what he has learnt in his years of experience.

Radical Adventure: An Inquiry into Psychedelic Psychotherapy Book

Auschwitz

1956 Hungarian uprising

Jon Hopkins Medical School

Psycholinguistics

LSD

Alcohol

Psilocybin

Freud

Timothy Leary

Aristotle

Support the Podcast

In this episode, Prof Nutt meets with Prof Alex Stevens, researcher in drug policy, treatment and harm reduction and Gillian Shorter, a researcher into the health and wellbeing of people who use alcohol and drugs.

In this episode they discuss harm reduction strategies in the UK. They delve into the root causes of the stigma surrounding substance use disorders and explore the effectiveness of various harm reduction approaches, such as needle exchange programs and drug consumption rooms. The conversation also considers the politics surrounding these strategies and the limitations imposed by the Misuse of Drugs Act.

Drug consumption Rooms BBC

Drug Science Enhanced Harm Reduction Working Group

Needle Exchange

Naloxone

Drug Consumption Room

High Tolerance Housing

The Merseyside Model

Drug Testing

Drug Testing Kits

International Harm Reduction Association

HIV and AIDS

Opiate Substitution Therapy

Winter Comfort Case Support the Podcast

What is the UK medical cannabis industry looking like in 2024?

We are 6 years on from legalisation of cannabis-based medical products in the UK and although many patients have now been able to access these products, many others are still struggling to get access.

In this episode of the Drug Science podcast, Prof. David Nutt is joined by three leading experts in cannabis science and the evolving landscape of regulation. Dr. Callie Seaman, Dr. Leon Barron, and Michael Sassano share their insights into the future of cannabis as a medicine, the current regulatory environment, and the scientific innovations driving the industry forward

Cannabis Industry Council

Medical Cannabis Working Group

SOMAI Pharmaceuticals

Medical Cannabis Clinicians Society

London Resilience Clinic

German medical cannabis market

NHS Cannabis-based products for medicinal use

Cost effectiveness paper

HHS report

This episode has been supported by the Cannabis Industry Council

In this episode, we meet with Darren Murphy, a Chemsex Specialist Practitioner at Forward Leeds, to discuss chemsex, addiction, as well as addressing the link with the LGBTQ+ community. Darren shares his personal journey, navigating the challenges of drug addiction and everything which came with it. Realising the limited support available for people engaging in chemsex, Darren shares how he uses his experiences to help others overcome similar struggles.

ChemSex and Being Safer

Methamphetamine

mephedrone

GHB

Poppers

Cocaine

Mdma

Ketamine

Eating disorder

HIV

Narcotics Anonymous

Support the podcast

In this episode, we sit down with Dr. Simon Ruffell, a psychiatrist and ayahuasca researcher with extensive experience working with Indigenous communities in the Amazon Basin. He discusses the potential of Indigenous medicines to complement Western psychiatric care and reduce relapse rates. Dr. Ruffell compares Western and Indigenous approaches to using spiritual plants, addressing the ongoing debate about how to respectfully integrate Indigenous medicine into Western healthcare as well as highlighting the key differences between commercial ayahuasca retreats and authentic Indigenous practices. Lastly, he discusses aspects of Shipibo culture and a journey into Shamanism.

Ayahuasca

DMT

Psilocybin

Psychosis

Revolving door syndrome

Shipibo

Heroic Hearts

Support the Podcast

Dr Simon Ruffell

Onaya Health

Onaya Science

Mind over matter

Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness

Ceremonial Ayahuasca in Amazonian Retreats

Modulatory effects of ayahuasca on personality structure in a traditional framework

In this episode, we meet with Dr Karenza Moore as she discusses changes in drug trends in the UK, focusing on the motivations, risks, and patterns of drug use, particularly among young people. Karenza identifies trends in drug use, including the impact of the lockdown on substance abuse. She also examines various drug trends within dance music culture, which leads to a discussion of safer partying practices, with a particular focus on the LGBT community and the importance of staying safe during a night out. Finally she addresses the challenges of conducting research in this area and outlines strategies for overcoming these barriers to gain a comprehensive understanding of substance use.

Ketamine

MDMA

Mephedrone

Release

Transform

Beckleys foundation

Support the podcast